As part of the 2024 Prostate Cancer Patient Conference, Dr. Ivan de Kouchkovksky discusses the use of both chemotherapy and radioligand therapy, including a “theranostic” approach, in metastatic treatment resistant prostate cancer.
Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39769]